The Pharmaceutical Market: Venezuela

Date: January 31, 2013
Pages: 143
Price:
US$ 1,295.00
License [?]:
Publisher: Espicom Business Intelligence
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: P24FA37A7C0EN
Leaflet:

Download PDF Leaflet

The Pharmaceutical Market: Venezuela
OVERVIEW OF THE PHARMACEUTICAL MARKET IN VENEZUELA

We expect the Venezuelan government to continue its foreign currency and import control policies in Q412 and the local market will endure further government restrictions on pharmaceutical and healthcare industry. Multinationals will have the potential revenue-generation opportunities from Venezuela's increasing reliance on imported products to meet local demand, as the election outcome will not fix the production capacity issues in the domestic industry.

Headline Expenditure Projections

Pharmaceuticals: VEB33.26bn (US$5.46bn) in 2011 to VEB40.77bn (US$6.00bn) in 2012; +22.6% in local currency terms and +10.0% in US dollar terms. Forecasts down due to new industrial information.

Healthcare: VEB66.69bn (US$10.94bn) in 2011 to VEB83.29bn (US$12.26bn) in 2012; +24.9% in local currency terms and +12.0% in US dollar terms. Forecasts up due to new macro data.

Medical devices: VEB9.62bn (US$1.58bn) in 2011 to VEB11.54bn (US$1.70bn) in 2012; +20.0% in local currency terms and 7.6% in US dollar terms. Forecasts down due to new macroeconomic data.

Competitive Landscape

The Competitive Landscape section provides comparative company analyses and rankings by US$ sales and % share of total sales - for the total pharmaceutical sector, as well as the OTC, generics, and distribution sub-sectors.
BMI INDUSTRY VIEW

SWOT

POLITICAL

ECONOMIC

BUSINESS ENVIRONMENT

INDUSTRY FORECAST

PHARMACEUTICAL MARKET FORECAST

   Table: Pharmaceutical Sales, 2009-2017

HEALTHCARE MARKET FORECAST

   Table: Overall Healthcare Expenditure, 2009-2017
   Table: Government Healthcare Expenditure, 2009-2017
   Table: Private Healthcare Expenditure, 2009-2017
   Table: VENEZUELA - ECONOMIC ACTIVITY

PRESCRIPTION DRUG MARKET FORECAST

   Table: Prescription Drug Sales, 2009-2017

PATENTED DRUG MARKET FORECAST

   Table: Patented Drug Sales, 2009-2017

GENERIC DRUG MARKET FORECAST

   Table: Generic Drug Sales, 2009-2017

OTC DRUG MARKET FORECAST

   Table: OTC Medicine Sales, 2009-2017

INDUSTRY FORECAST IMPORT/EXPORT

   Table: Pharmaceutical Trade, 2009-2017
   Table: Pharmaceutical Trade, 2008-2016

MEDICAL DEVICES FORECAST

   Table: Table: Medical Device Sales, 2009-2017

INDUSTRY FORECAST OTHER HEALTHCARE DATA

KEY RISKS TO BMI'S FORECAST SCENARIO

INDUSTRY RISK REWARD RATINGS

   Table: Table: Americas Pharmaceutical Risk/Reward Ratings, Q113

MARKET OVERVIEW

INDUSTRY TRENDS AND DEVELOPMENTS

  Epidemiology
  Communicable Diseases
  Non-Communicable Diseases..
  Healthcare Sector Developments
  Hospital Sector
  Private Healthcare Sector
  Supply Chain
   Table: Members of CAVEDRO, 2009
  Research & Development
  Medical Devices

REGULATORY DEVELOPMENT

  Regulatory Regime
  Intellectual Property
  Regulatory Developments
  Pharmaceutical Registration
   Table: Registration Requirements
   Table: Renewal Requirements
  Advertising..
  Biologics And Biosimilars
  Intellectual Property Issues
  International Collaboration
  Pricing
  Reimbursement

COMPETITIVE LANDSCAPE

  Pharmaceutical Sector
  Foreign Industry
  Domestic Industry
   Table: Members of CAMESIP, 2010
  Pharmaceutical Distribution
   Table: Members of CAVEFAR, 2009
  Production
   Table: Members of CAVEME, 2010
   Table: Members of CIFAR, 2010
  Company Developments

COMPANY PROFILE

GRUPO FARMA

ELMOR

STRIDES LATINA (SUMIFARMA)

CALOX INTERNATIONAL

PFIZER

SANOFI

GLAXOSMITHKLINE

BOEHRINGER INGELHEIM

NOVARTIS

MERCK & CO.

DEMOGRAPHIC FORECAST

VENEZUELA DEMOGRAPHIC DATA

  Table: Venezuela's Population By Age Group, 1990-2020 ('000)
  Table: Venezuela's Population By Age Group, 1990-2020 (% of total)
  Table: Venezuela's Key Population Ratios, 1990-2020
  Table: Venezuela's Rural And Urban Population, 1990-2020

GLOSSARY

METHODOLOGY

METHODOLOGY

RISK/REWARD RATINGS METHODOLOGY

RATINGS OVERVIEW

  Table: Pharmaceutical Business Environment Indicators

WEIGHTING

  Table: Weighting Of Components

SOURCES
Skip to top


The Pharmaceutical Market: Hungary US$ 1,295.00 Jan, 2013 · 95 pages
The Pharmaceutical Market: India US$ 1,295.00 Jan, 2013 · 117 pages
The Pharmaceutical Market: Indonesia US$ 1,295.00 Jan, 2013 · 117 pages

Ask Your Question

The Pharmaceutical Market: Venezuela
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: